Concepedia

Thomas McFarland

TM

Statistics

Publications

17

Citations

515

H-Index

14

Active since

1984

Affiliations

University of Wisconsin–Madison(Current)

Aspirus Wausau Hospital

University of Wisconsin Carbone Cancer Center

University of Wisconsin–Green Bay

University of Wisconsin Health

Thomas McFarland is an author at University of Wisconsin–Madison specializing in medicine, oncology, and malignant neoplasms.

Publications per year

1984–2018

17

Publications

17

Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network

Brad S. Kahl, Walter Longo, Jens C. Eickhoff et al. · Annals of Oncology · 2006 · 113 citations · Full text

Medicine, Immunology, Oncology +12

VcR‐CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study

Christopher G. Peterson, Sangbum Choi, Jens C. Eickhoff et al. · British Journal of Haematology · 2011 · 51 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Low T8 antigen density on lymphocytes in active multiple sclerosis

Anthony T. Reder, Jack P. Antel, Joël Oger et al. · Annals of Neurology · 1984 · 46 citations

Life Sciences, Cell Biology, Immunology +17

Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma

Mark R. Albertini, Richard K. Yang, Erik A. Ranheim et al. · Cancer Immunology Immunotherapy · 2018 · 44 citations · Full text

Medicine, Immunology, Oncology +13

Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network

Vaishalee P. Kenkre, Walter L. Long, Jens C. Eickhoff et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 40 citations

Medicine, Geriatric Medicine, Oncology +16

1–5 of 17